Kim Ace Global Big Pharma ETF (KRX:497510)

Assets	8.85B
Expense Ratio	0.30%
PE Ratio	22.97
Dividend (ttm)	288.00
Dividend Yield	2.27%
Ex-Dividend Date	Jul 30, 2026
Payout Frequency	Quarterly
Payout Ratio	52.19%
1-Year Return	+28.24%

Volume	771
Open	12,675
Previous Close	12,675
Day's Range	12,630 - 12,690
52-Week Low	9,850
52-Week High	14,990
Beta	n/a
Holdings	n/a
Inception Date	Nov 19, 2024

About 497510

497510.KQ was created on 2024-11-19 by ACE. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 8789.32m in AUM and 17 holdings. KIM ACE Global Big Pharma ETF is an exchange-traded fund incorporated in South Korea. The objective of the fund is to achieve return that closely replicates the performance of Solactive Global Big Pharma Index PR

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 497510
• Provider: ACE
• Index Tracked: Solactive Global Big Pharma Index - Benchmark Price Return

Performance

497510 had a total return of 28.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.73%.

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 30, 2026	79.000 KRW	Aug 4, 2026
Apr 29, 2026	100.000 KRW	May 6, 2026
Jan 29, 2026	58.000 KRW	Feb 3, 2026
Oct 30, 2025	51.000 KRW	Nov 4, 2025
Jul 30, 2025	60.000 KRW	Aug 4, 2025
Apr 29, 2025	112.000 KRW	May 7, 2025

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error